Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis Viruses”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04113629
What this trial is testing

Simplified Monitoring Myanmar SM2 Study

Who this might be right for
Hepatitis CLiver CirrhosesLiver Inflammation+1 more
Kirby Institute 200
Early research (Phase 1)Study completedNCT01094873
What this trial is testing

Study of a Novel Therapeutic Vaccine for Hepatitis C Virus

Who this might be right for
Hepatitis C
ReiThera Srl 35
Early research (Phase 1)Study completedNCT00906256
What this trial is testing

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

Who this might be right for
Healthy
Arrow Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT01707472
What this trial is testing

Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

Who this might be right for
Liver FibrosisHepatitis CHIV+1 more
Gilead Sciences 18
Not applicableStudy completedNCT03931239
What this trial is testing

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Vabiotech 222
Testing effectiveness (Phase 2)Study completedNCT04000737
What this trial is testing

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Yiviva Inc. 62
Very early researchNot Yet RecruitingNCT06745973
What this trial is testing

An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Epigenic Therapeutics, Inc 20
Testing effectiveness (Phase 2)Study completedNCT07417553
What this trial is testing

Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

Who this might be right for
Chronic Hepatitis B-related Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 67
Early research (Phase 1)Ended earlyNCT06159062
What this trial is testing

A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B Virus Infection
Yangshengtang Co., Ltd 1
Not applicableEnded earlyNCT00318682
What this trial is testing

Evaluation and Medico-Economic Study of FIBROSCAN in Patients With Viral Hepatitis

Who this might be right for
Hepatitis, Viral, Human
Assistance Publique - Hôpitaux de Paris 2,000
Not applicableStudy completedNCT00476723
What this trial is testing

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

Who this might be right for
HIVHepatitis-B
The HIV Netherlands Australia Thailand Research Collaboration 36
Not applicableEnrolling By InvitationNCT05956379
What this trial is testing

Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.

Who this might be right for
Chronic Hepatitis BNon-alcoholic Fatty Liver Disease
National Taiwan University Hospital 100
Large-scale testing (Phase 3)Study completedNCT02032875
What this trial is testing

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 116
Post-approval studies (Phase 4)UnknownNCT02281266
What this trial is testing

Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection

Who this might be right for
Curable Hepatitis B Virus-Related Hepatocellular Carcinoma
Jia Fan 360
Testing effectiveness (Phase 2)Ended earlyNCT01440595
What this trial is testing

Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 5
Large-scale testing (Phase 3)Study completedNCT01276756
What this trial is testing

Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis c
Cairo University 100
Early research (Phase 1)Study completedNCT00718172
What this trial is testing

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 81
Not applicableUnknownNCT05094869
What this trial is testing

Prevention of HCC Using Mobile Phone Applications

Who this might be right for
Liver CirrhosisHepatitis B
Beijing Friendship Hospital 8,000
Large-scale testing (Phase 3)Study completedNCT02806505
What this trial is testing

HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 81
Early research (Phase 1)Study completedNCT00903773
What this trial is testing

VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.

Who this might be right for
Hepatitis CKidney Diseases
Tibotec BVBA 24
Next Page